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LETTER
SIGMOID COLON ADENOCARCINOMA: 9 YEARS
FROM DIAGNOSIS TO TREATMENT
Belchor Fontes, Cornelius Mitteldorf, Renato Sérgio Poggetti, Leonardo Toledo
Mota, Nivaldo Cabral, and Dario Birolini
Colon adenocarcinoma represents the third most fre-
quent cause of death by cancer, being surpassed only by
lung or stomach cancer, and it has motivated many studies
in the past 5 decades.1,2 The probable diagnosis is usually
based on clinical data, which mainly comprise anemia, low
digestive tract bleeding, abdominal pain, and weight loss.
Over the last 20 years, colonoscopy became the main in-
vestigative tool for colon cancer diagnosis, allowing visu-
alization and biopsy of diverse colonic lesions and fre-
quently the removal of benign or malignant polyps.
At present, once the diagnosis of colon cancer is con-
firmed, whenever endoscopic resection is not feasible, sur-
gical treatment is prescribed and not postponed. Colon
tumor recurrence has been reported in 25% to 30% of pa-
tients undergoing surgery for stage II (AJCC) and in up to
60% for stage III (AJCC) colon cancer.3 Therefore, for these
patients, chemotherapy and radiotherapy are frequently in-
dicated after surgical treatment.4,5 The overall 5-year sur-
vival rate for patients with colon cancer has been reported
to be up to 65%.1,6 However, in the reviewed literature there
was no report on the survival of patients with diagnosed
colon cancer who did not undergo surgery, chemotherapy,
or radiotherapy.
CASE DESCRIPTION
A 61-year-old woman presented low digestive tract
bleeding in December 1993 with no other symptoms. A
colonoscopy was then performed and revealed a vegetative
injury at 25 cm above the anal verge. The lesion had an
infiltrative aspect and comprised half of the colon circum-
ference in a 3 cm extension. The biopsy of the lesion re-
vealed a villous adenocarcinoma. The patient refused the
proposed surgical treatment and evolved with occasional
bleeding episodes. After mid 2000, the patient presented
infrequent episodes of abdominal pain, and in January
2001, by request of another surgeon, she underwent a sec-
ond colonoscopy that revealed a sigmoid colon neoplasia
that was not completely stenosed but that did not allow pro-
gression of the colonoscope. The biopsy result revealed a
well differentiated tubulovillous adenocarcinoma.
Once again the patient refused the proposed surgical
treatment. In July 2002, the abdominal pain worsened,
weight loss and weakness occurred, and an initially dis-
crete abdominal volume increase was observed. Thereaf-
ter, a slow and progressive increase in the severity of this
clinical condition was observed. Finally, in December 2002,
9 years after the initial diagnosis of the colon cancer, the
abdominal pain was intense and continuous, and vomiting
was frequent. With the increasing severity of the clinical
picture, the patient sought urgent medical care.
On physical examination the patient was awake and
alert and had pale skin. Her abdomen was distended and
painful, with rebound tenderness, allowing the diagnosis
of acute abdomen with signs of peritonitis. An exploratory
laparotomy was proposed and the patient agreed.
Preoperative laboratory blood tests were normal except for
a hemoglobin concentration of 6 g/dL. After fluid replace-
ment and blood transfusion, the patient underwent an ex-
ploratory median laparotomy that revealed a ruptured
abdominopelvic cyst involving the left ovary and adhering
to pelvic organs. Voluminous mucous material had extrava-
sated from the cyst to the peritoneal cavity. The pelvic cav-
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ity was occupied by the mucous material containing cystic
debris. A partial sigmoid occlusion provoked by the tumor
was identified. A panhysterectomy, with removal of the pel-
vic debris as well as the remnants of the ruptured cyst was
performed. A sigmoidectomy was performed, the rectal
stump was closed with suture, the end of the descendent
colon was exteriorized as a colostomy (Hartmann proce-
dure), and the abdominal cavity was closed.
The anatomicopathologic examination of the removed
tissues confirmed a 7 cm diameter tubulovillous sigmoid
adenocarcinoma infiltrating the pericolic adipose tissue,
without vascular, lymphatic, or perineural infiltration. One
of the 11 mesenteric ganglions removed was compromised
by the neoplasia. In the left ovary, a metastatic intestinal
adenocarcinoma was found with the same histologic type
as that of the sigmoid adenocarcinoma. The tumor was thus
classified as stage IV (TNM/AJCC6).
The patient presented an uneventful postoperative
course and refused the complementary chemotherapy in-
dicated by the oncologist. Twenty four months after the sur-
gery, the patient´s weight had increased by 12 kg, she was
asymptomatic, with normal values of the carcinoembryonic
antigen and normal colonoscopy, abdominal CT scan, and
plain thorax radiography. The patient elected to postpone
the intestinal transit reconstruction with colostomy closure.
DISCUSSION
This reported case draws attention to the long survival
(9 years) of a patient with colon carcinoma without medi-
cal treatment, either through surgery, chemotherapy, or ra-
diotherapy. The growing and metastasizing potential of co-
lon adenocarcinoma has been intensively investigated in the
last 5 decades. The type and stage of tumor (generally ex-
pressed in terms of TMN/AJCC classifications), as well as
the patient’s age, gender, genetic, and biochemical at-
tributes, and even the response to environmental influences,
have been discussed as possible factors influencing the
growth and expansion of a colon adenocarcinoma.7 In the
present case, the patient had no history of previous health
disturbances or familial diseases deserving consideration.
Although earlier studies investigated the growth veloc-
ity of colon cancer,8,9,10 the diagnostic tools employed in those
studies were rather limited, and no posterior and compara-
tive studies have been reported to allow an estimation of co-
lon tumor age, on the basis of its size when diagnosed. The
localization of the tumor in the colon as well as the gender
of the patient seems not to have an influence on the prog-
nosis.7 The usual tumor classification system (TNM/AJCC)
is based on the tumor extension on the colon wall and the
presence of metastasis in lymph nodes or in distant organs.
However, tumors at the same initial stage may show rapid
or slow growth and may have early or late metastasis.
Furthermore, the factors governing this biologic
behavior of colon cancer as well as its influence on the
patient´s survival have not been clearly determined.
In a recent prospective study of 2,452 patients, Staib
et al.1 verified that the 5- and 10-year survival rate of pa-
tients treated for stage IV colon adenocarcinoma was, re-
spectively, 3.4% and 0%. In the present case, the patient
was classified with a stage IV colon adenocarcinoma, there-
fore with a low probability for survival for 5 or 10 years.
According to some authors, in young patients (under 40
years of age), colon adenocarcinoma usually is diagnosed
in advanced stages and presents more aggressive histologi-
cal types, such as mucinous adenocarcinoma or signet ring
cells, and consequently has an unfavorable prognosis.11
However, it has been reported that young patients with
even advanced stage colon cancer have a higher 5-year sur-
vival rate, when compared to older patients.12 Therefore,
the influence of patient age on colon cancer prognosis re-
mains unclear. Several studies suggest the existence of a
relationship between the patient’s prognosis and the tumor
cell ploidy, the presence of lymph node micrometastasis
or cytokeratins, microsatellite instability, chromosomic de-
letion, and P53 gene activity. However, the possible clini-
cal application of these tumor markers remains unclear.11,13
Genetic analysis of Dukes B stage epithelium colon can-
cer identified 23 genes that showed correlation with a poor
patient prognosis, determining faster tumor growth and
early occurrence of metastasis.13 However, the possible role
of these genes on patient survival remains to be determined.
Therefore, current knowledge based on reviewed litera-
ture does not allow the determination of the factors that
contributed to the extended survival of the patient in this
case report.
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